- Nachrichtendetail
-
27.06.2024 14:15:19 - dpa-AFX: *LIGAND PARTNER VERONA PHARMA ANNOUNCES FDA APPROVAL OF OHTUVAYRE FOR MAINTENANCE TREATMENT OF COPD
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
LIGAND PHARMAC.NEW DL-001 | A1C9RN | Frankfurt | 85,000 | 08.08.24 08:49:15 | -3,000 | -3,41% | 84,500 | 86,000 | 85,000 | 88,000 |
